Deep Venous Arterialization: Indications, Technique, and Data

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker's Bureau - Bard Medical; Terumo Medical Corporation; Medtronic; Abbott; Boston Scientific Corporation; Philips; W.L. Gore & Associates
• Equity/Stock(s)/Options - 2MG; Cardioflow; Vantis
• Research - Boston Scientific Corporation; CardioFlow; Micromedical Solutions; Reflow Medical
• Royalty/Intellectual Property Rights - Reflow Medical